Colibri hires Horn as chief executive

BROOMFIELD – Colibri Heart Valve LCC in Broomfield hired Joseph B. Horn as the medical-device company’s president and chief executive.

Colibri is known for developing a heart valve that can be implanted without requiring full open heart surgery.

Horn has spent the last 30-plus years in the medical industry, ranging from orthopedics to cardiovascular applications. He has focused on cardiology for the last 25 years.

SPONSORED CONTENT

How dispatchable resources enable the clean energy transition

Platte River must prepare for the retirement of 431 megawatts (MW) of dispatchable, coal-fired generation by the end of the decade and address more frequent extreme weather events that can bring dark calms (periods when there is no sun or wind).

“Having been in the cardiovascular medical-device industry for most of my career, I was impressed by the potential for Colibri’s TAVI (transcatheter aortic valve implantation) device to revolutionize the transcatheter aortic heart valve market,” Horn said in a press statement.

“Given the significant advantages offered by Colibri’s system over existing options, I believe Colibri’s TAVI device has great potential to impact what is predicted to be one of the largest cardiovascular growth markets,” he said. “We are finalizing plans for our first-in-human study in patients with a symptomatic stenotic aortic valve who are candidates for TAVI, which we expect to complete in identified centers in Western Europe early next year.”

Horn last served as a president of a Cook Group company, Global Therapeutics, a company he founded in 1990 where he was responsible for the development and marketing of vascular products in more than 40 countries. Global Therapeutics was acquired by Cook in 1998.

Colibri’s corporate headquarters and precommercialization facilities are located in Broomfield, and its research and development operations are in Houston.